255 related articles for article (PubMed ID: 26271387)
1. Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response.
Talotta R; Berzi A; Atzeni F; Batticciotto A; Clerici M; Sarzi-Puttini P; Trabattoni D
J Clin Immunol; 2015 Aug; 35(6):550-7. PubMed ID: 26271387
[TBL] [Abstract][Full Text] [Related]
2. Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion.
Guggino G; Giardina AR; Raimondo S; Giardina G; Sireci G; Dieli F; Peralta M; Alessandro R; Triolo G; Ciccia F
Clin Exp Rheumatol; 2014; 32(1):77-81. PubMed ID: 24429356
[TBL] [Abstract][Full Text] [Related]
3. Anti-TNF therapy in patients with rheumatoid arthritis decreases Th1 and Th17 cell populations and expands IFN-γ-producing NK cell and regulatory T cell subsets.
Aravena O; Pesce B; Soto L; Orrego N; Sabugo F; Wurmann P; Molina MC; Alfaro J; Cuchacovich M; Aguillón JC; Catalán D
Immunobiology; 2011 Dec; 216(12):1256-63. PubMed ID: 21840621
[TBL] [Abstract][Full Text] [Related]
4. Exogenous IL-2 controls the balance in Th1, Th17, and Treg cell distribution in patients with progressive rheumatoid arthritis treated with TNF-alpha inhibitors.
Kosmaczewska A; Ciszak L; Swierkot J; Szteblich A; Kosciow K; Frydecka I
Inflammation; 2015 Apr; 38(2):765-74. PubMed ID: 25145773
[TBL] [Abstract][Full Text] [Related]
5. The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: a follow-up study.
Szalay B; Vásárhelyi B; Cseh A; Tulassay T; Deák M; Kovács L; Balog A
Clin Rheumatol; 2014 Feb; 33(2):175-85. PubMed ID: 23934385
[TBL] [Abstract][Full Text] [Related]
6. The Expression of P2X7 Receptor on Th1, Th17, and Regulatory T Cells in Patients with Systemic Lupus Erythematosus or Rheumatoid Arthritis and Its Correlations with Active Disease.
Li M; Yang C; Wang Y; Song W; Jia L; Peng X; Zhao R
J Immunol; 2020 Oct; 205(7):1752-1762. PubMed ID: 32868411
[TBL] [Abstract][Full Text] [Related]
7. Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy.
McGovern JL; Nguyen DX; Notley CA; Mauri C; Isenberg DA; Ehrenstein MR
Arthritis Rheum; 2012 Oct; 64(10):3129-38. PubMed ID: 22674488
[TBL] [Abstract][Full Text] [Related]
8. Serum IL-35 is decreased in overweight patients with rheumatoid arthritis: its correlation with Th1/Th2/Th17-related cytokines.
Li Y; Jie Y; Wang X; Lu J
BMC Immunol; 2021 Jun; 22(1):42. PubMed ID: 34176464
[TBL] [Abstract][Full Text] [Related]
9. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
10. Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement.
Kosmaczewska A; Swierkot J; Ciszak L; Szteblich A; Chrobak A; Karabon L; Partyka A; Szechinski J; Wiland P; Frydecka I
Rheumatol Int; 2014 Feb; 34(2):243-53. PubMed ID: 24221190
[TBL] [Abstract][Full Text] [Related]
11. Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients.
Pesce B; Soto L; Sabugo F; Wurmann P; Cuchacovich M; López MN; Sotelo PH; Molina MC; Aguillón JC; Catalán D
Clin Exp Immunol; 2013 Mar; 171(3):237-42. PubMed ID: 23379428
[TBL] [Abstract][Full Text] [Related]
12. IL-37 Alleviates Rheumatoid Arthritis by Suppressing IL-17 and IL-17-Triggering Cytokine Production and Limiting Th17 Cell Proliferation.
Ye L; Jiang B; Deng J; Du J; Xiong W; Guan Y; Wen Z; Huang K; Huang Z
J Immunol; 2015 Jun; 194(11):5110-9. PubMed ID: 25917106
[TBL] [Abstract][Full Text] [Related]
13. Th1 responses are more susceptible to infliximab-mediated immunosuppression than Th17 responses.
Kanayama K; Nakamura K; Ogino H; Sumida Y; Ihara E; Akiho H; Takayanagi R
Dig Dis Sci; 2011 Dec; 56(12):3525-33. PubMed ID: 21678051
[TBL] [Abstract][Full Text] [Related]
14. T-Cell Subsets in Rheumatoid Arthritis Patients on Long-Term Anti-TNF or IL-6 Receptor Blocker Therapy.
Dulic S; Vásárhelyi Z; Sava F; Berta L; Szalay B; Toldi G; Kovács L; Balog A
Mediators Inflamm; 2017; 2017():6894374. PubMed ID: 29209104
[TBL] [Abstract][Full Text] [Related]
15. Ex-Th17 (Nonclassical Th1) Cells Are Functionally Distinct from Classical Th1 and Th17 Cells and Are Not Constrained by Regulatory T Cells.
Basdeo SA; Cluxton D; Sulaimani J; Moran B; Canavan M; Orr C; Veale DJ; Fearon U; Fletcher JM
J Immunol; 2017 Mar; 198(6):2249-2259. PubMed ID: 28167631
[TBL] [Abstract][Full Text] [Related]
16. Resolution of Th/Tc17-driven inflammation during anti-TNFα treatment of rheumatoid arthritis reveals a unique immune biomarker profiling pattern.
Bjarnadóttir U; Einarsdóttir HK; Stefánsdóttir E; Helgason EA; Jónasdóttir D; Gudmundsson S; Gudbjornsson B; Ludviksson BR
Scand J Immunol; 2022 Jan; 95(1):e13116. PubMed ID: 35213743
[TBL] [Abstract][Full Text] [Related]
17. Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis.
Miao J; Zhang K; Lv M; Li Q; Zheng Z; Han Q; Guo N; Fan C; Zhu P
Scand J Rheumatol; 2014; 43(3):194-201. PubMed ID: 24392804
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.
Thiolat A; Semerano L; Pers YM; Biton J; Lemeiter D; Portales P; Quentin J; Jorgensen C; Decker P; Boissier MC; Louis-Plence P; Bessis N
Arthritis Rheumatol; 2014 Feb; 66(2):273-83. PubMed ID: 24504799
[TBL] [Abstract][Full Text] [Related]
19. Th1-Th17 Ratio as a New Insight in Rheumatoid Arthritis Disease.
Bazzazi H; Aghaei M; Memarian A; Asgarian-Omran H; Behnampour N; Yazdani Y
Iran J Allergy Asthma Immunol; 2018 Feb; 17(1):68-77. PubMed ID: 29512371
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study.
Talotta R; Berzi A; Atzeni F; Dell'Acqua D; Sarzi Puttini P; Trabattoni D
Reumatismo; 2016 Sep; 68(2):83-9. PubMed ID: 27608796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
